Early Menopause and Premature Ovarian Insufficiency: When It Happens Before 40

You are 34, and your periods stopped six months ago. Or you are 28, and you have been told your FSH levels are those of someone decades older. Or you are 37, and a cancer treatment has pushed you into menopause years before you expected it. Menopause before 40 is not just early. It is a different clinical situation with different implications, and it requires a different conversation than menopause at 51.

The plain version: premature ovarian insufficiency (POI) means the ovaries stop functioning normally before age 40. It is more common than was once thought: the 2024 international guideline cites newer data putting it at about 3.5 percent of women [6]. The cause is often unknown, though autoimmune conditions, genetics and medical treatments are recognized causes. Because the estrogen deficiency occurs years or decades before it naturally would, POI carries specific long-term health risks: accelerated bone loss, increased cardiovascular risk, and potential effects on cognitive function. Hormone therapy is recommended until at least age 51 to replace the estrogen the body would have produced. This is hormone replacement in the truest sense, not the same risk-benefit trade-off as hormone therapy at typical menopause age.

What’s going on

In typical menopause, the ovaries gradually reduce their hormone production over several years, with the final menstrual period occurring around age 51 on average. In POI, this process happens prematurely. The ovaries either run out of follicles earlier than expected, or the follicles stop responding to the signals from the pituitary gland that normally trigger ovulation and hormone production [1].

The distinction between POI and early menopause matters. Early menopause (final period between ages 40 and 45) has overlapping concerns but is more common and tends to follow a pattern similar to typical menopause. POI before age 40 is less common, may have different underlying causes, and carries greater long-term health significance because of the longer duration of estrogen deficiency.

In most cases of POI, the cause is not identified. When a cause is found, the most common categories are:

• Autoimmune conditions. The immune system attacks the ovaries. POI may occur alongside other autoimmune conditions like thyroid disease, Addison disease or type 1 diabetes.
• Genetic factors. Turner syndrome, Fragile X premutation carriers, and other chromosomal or genetic variations can affect ovarian function.
• Medical treatments. Chemotherapy, radiation to the pelvis, and surgical removal of the ovaries (bilateral oophorectomy) can cause immediate or accelerated loss of ovarian function.

The health consequences of prolonged estrogen deficiency are well documented. A review of long-term outcomes found that premature menopause is associated with increased risk of osteoporosis, cardiovascular disease, cognitive decline and increased all-cause mortality compared with menopause at the typical age [4]. The earlier the menopause, the greater the cumulative risk.

Is it the change, or something else?

Suggests POI	Overlaps with other conditions	Needs prompt attention
Absent or irregular periods before age 40	Hypothalamic amenorrhea (from extreme exercise, low weight or stress)	Complete absence of periods in someone under 40
Hot flashes and night sweats in your twenties or thirties	Thyroid disease (can cause cycle irregularity)	Symptoms following chemotherapy or radiation
Elevated FSH levels on blood testing	Polycystic ovary syndrome (irregular periods but different mechanism)	Emotional distress about diagnosis, fertility or health implications
Vaginal dryness and decreased libido at a young age	Pituitary disorders (affect hormone signaling)	Signs of an associated autoimmune condition

A diagnosis of POI is based on at least four months of absent or irregular periods before age 40 plus a raised FSH level. The 2016 guideline asked for two raised FSH results at least four weeks apart [1]. The 2024 update says one FSH result above 25 IU/L is enough, with a repeat FSH or an AMH test where the picture is unclear [6].

What helps, and how well

Hormone therapy. This is the cornerstone of POI management. Guidelines from ESHRE, The Menopause Society and NICE all recommend hormone therapy until at least the average age of natural menopause (around 51) [1] [2] [3]. The purpose is to replace the estrogen the body would have been producing. NICE specifically notes that the usual balance of risks and benefits for HRT at typical menopause age does not apply to people with POI, because they are replacing a deficit rather than supplementing a natural decline [3].

POI in four numbersPremature ovarian insufficiency at a glance

• <40Age when the ovaries stop working normally
• 3.5%Of women affected, per newer data in the 2024 guideline
• 51Hormone therapy until at least this age
• 5-10%Of cases still have sporadic ovulation

How strong is the evidence? Strong for the recommendation to provide hormone replacement. The long-term health risks of untreated POI (bone loss, cardiovascular disease, potential cognitive effects) are well documented.

Hormone therapy for POI can use standard menopause regimens (transdermal estradiol with micronized progesterone for people with a uterus) or the combined oral contraceptive pill, which also provides estrogen and is sometimes preferred by younger people because it is socially familiar and also provides contraception [5]. The choice depends on individual circumstances and preferences.

Bone monitoring. Because bone loss begins earlier and continues longer, a DEXA scan is recommended at diagnosis and periodically thereafter. Adequate calcium, vitamin D and weight-bearing exercise are important alongside hormone therapy.

Cardiovascular monitoring. Regular monitoring of blood pressure, lipids and blood sugar is recommended, with attention to the fact that cardiovascular risk is elevated relative to age-matched peers.

Fertility. POI significantly reduces fertility, but it does not eliminate it entirely. Sporadic ovulation occurs in about 5 to 10 percent of cases. For people who wish to conceive, options include donor eggs and, in some situations, ovarian tissue cryopreservation (if the diagnosis occurs before complete follicle depletion). A reproductive endocrinologist can discuss the options [1].

Psychological support. A diagnosis of POI in your twenties or thirties can be profoundly disorienting. It may affect body image, identity, relationships and plans for the future. Psychological support or counseling is recommended as part of the management plan [1].

Autoimmune screening. Because of the association with autoimmune conditions, screening for thyroid disease and adrenal insufficiency (at minimum) is recommended at diagnosis and periodically.

Take this to your appointment

1. My periods have stopped (or become very irregular) and I am under 40. Can we check my FSH and estradiol levels?
2. I have been diagnosed with POI. What is the recommended hormone therapy, and how long should I take it?
3. Should I be screened for autoimmune conditions or genetic causes?
4. When should I have a DEXA scan, and how often should it be repeated?
5. I would like to discuss fertility options. Can you refer me to a reproductive endocrinologist?
6. I am struggling with this diagnosis emotionally. Can you recommend counseling or a support group?

See a clinician promptly if… you have any bleeding after 12 months without a period, very heavy or prolonged bleeding, new chest pain, a painful swollen leg or sudden shortness of breath, or low mood that won’t lift. If you are thinking about harming yourself, call or text 988 in the US, or call 911 in an emergency. This article is general education, not medical advice.

Related reading: Hormone Therapy Risks: Put the Headlines in Numbers | Bone Density and Osteoporosis in Menopause